Sydnexis

Developer of a therapeutic formulation for treating myopia

placeDel Mar, California, United States calendar_todayFounded 2014 language sydnexis.com

Innovation

8 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 5,069 times.

YearFilings
20151
20164
20171
20182
20192
20204
20215
20224
20234
20245
20256
20261

Social engagement

Social engagement: 2.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Visionary Ventures, SC Master Fund, Bluestem Capital.

Investor typeCountShare
Venture capital350%
Private equity233%
Other / undisclosed117%

Recent activity

23 Jun 2026
Product launch
SYD-101
Coming soon